RPTX/ 11/14/2025 · 5:02 PM Repare Therapeutics to Be Acquired by XenoTherapeutics Repare Therapeutics (RPTX) announces acquisition by XenoTherapeutics for $1.82/share plus contingent value rights, expected to close Q1 2026.
